KEVIN TEMPLE: Open Payments
NPI 1790152346 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 11 payments from 6 companies in 2025. Trend: 2023 $669 · 2024 $480 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $88 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: FARXIGA, OPSUMIT, AVEIR, ELIQUIS, CDS - MCT/CEM Monitoring, Kerendia.
Industry payments across TX — which companies pay providers there.
